Chitosan in Oral Drug Delivery Formulations: A Review

被引:19
|
作者
Sangnim, Tanikan [1 ]
Dheer, Divya [2 ,3 ]
Jangra, Nitin [2 ]
Huanbutta, Kampanart [4 ]
Puri, Vivek [2 ]
Sharma, Ameya [2 ]
机构
[1] Burapha Univ, Fac Pharmaceut Sci, Chon Buri 20131, Thailand
[2] Chitkara Univ, Chitkara Sch Pharm, Baddi 174103, Himachal Prades, India
[3] Inst Nano Sci & Technol, Chem Biol Unit, Knowledge City,Sect 81, Mohali 140306, Punjab, India
[4] Rangsit Univ, Dept Mfg Pharm, Coll Pharm, Pathum Thani 12000, Thailand
关键词
chitosan; nanoformulations; oral drug delivery; herbal bioactives; patents; CARBOXYMETHYL CHITOSAN; POLYMERIC MICELLES; NANOPARTICLES; SYSTEMS; BIOAVAILABILITY; NANOTECHNOLOGY; PACLITAXEL; RELEASE;
D O I
10.3390/pharmaceutics15092361
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoformulations have become increasingly useful as drug delivery technologies in recent decades. As therapeutics, oral administration is the most common delivery method, although it is not always the most effective route because of challenges with swallowing, gastrointestinal discomfort, low solubility, and poor absorption. One of the most significant barriers that medications must overcome to exert a therapeutic effect is the impact of the first hepatic transit. Studies have shown that controlled-release systems using nanoparticles composed of biodegradable natural polymers significantly improve oral administration, which is why these materials have attracted significant attention. Chitosan possesses a wide variety of properties and functions in the pharmaceutical as well as healthcare industries. Drug encapsulation and transport within the body are two of its most important features. Moreover, chitosan can enhance drug efficacy by facilitating drug interaction with target cells. Based on its physicochemical properties, chitosan can potentially be synthesized into nanoparticles, and this review summarizes recent advances and applications of orally delivered chitosan nanoparticle interventions.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] A comprehensive review of oral chitosan drug delivery systems: Applications for oral insulin delivery
    Alfatama, Mulham
    Choukaife, Hazem
    Alkhatib, Hamzeh
    Al Rahal, Okba
    Zin, Nur Zahirah Mohamad
    NANOTECHNOLOGY REVIEWS, 2024, 13 (01)
  • [2] Drug delivery to the intestinal lymph by oral formulations
    Yoshida, Takayuki
    Kojima, Hiroyuki
    Sako, Kazuhiro
    Kondo, Hiromu
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2022, 27 (02) : 175 - 189
  • [3] Chitosan hybrid microgels for oral drug delivery
    Galdioli Pella, Michelly Cristina
    Simao, Andressa Renatta
    Lima-Tenorio, Michele Karoline
    Tenorio-Neto, Ernandes
    Scariot, Debora Botura
    Nakamura, Celso Vataru
    Rubira, Adley Forti
    CARBOHYDRATE POLYMERS, 2020, 239
  • [4] CHITOSAN / HEXAMOLYBDATE NANOSTRUCTURES FOR ORAL DRUG DELIVERY
    Kadhim, Mariam Radhi
    Shaheed, Ihsan Mahdi
    Al-Yasari, Ahmed
    PERIODICO TCHE QUIMICA, 2024, 21 (47):
  • [5] Chitosan nanoparticles for oral drug and gene delivery
    Bowman, Katherine
    Leong, Kam W.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (02): : 117 - 128
  • [6] A review on chitosan and its nanocomposites in drug delivery
    Ali, Akbar
    Ahmed, Shakeel
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 109 : 273 - 286
  • [7] Drug delivery applications of chitin and chitosan: a review
    Parhi, Rabinarayan
    ENVIRONMENTAL CHEMISTRY LETTERS, 2020, 18 (03) : 577 - 594
  • [8] Drug delivery applications of chitin and chitosan: a review
    Rabinarayan Parhi
    Environmental Chemistry Letters, 2020, 18 : 577 - 594
  • [9] Stability of liposomal formulations in physiological conditions for oral drug delivery
    Taira, MC
    Chiaramoni, NS
    Pecuch, KM
    Alonso-Romanowski, S
    DRUG DELIVERY, 2004, 11 (02) : 123 - 128
  • [10] Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
    Fricker, Gert
    Kromp, Torsten
    Wendel, Armin
    Blume, Alfred
    Zirkel, Juergen
    Rebmann, Herbert
    Setzer, Constanze
    Quinkert, Ralf-Olaf
    Martin, Frank
    Mueller-Goymann, Christel
    PHARMACEUTICAL RESEARCH, 2010, 27 (08) : 1469 - 1486